Growth Operating System Diagnostic: 90-Day Checklist for B2B Teams

Ninety days is enough time to know whether your commercial system has structural problems. It is not enough time to fix them all. But it is enough time to stop pretending the problems are noise.

This checklist is built for founders and revenue leaders who want to move from a vague sense that something is off to a specific, prioritised picture of where the system is breaking. Work through it in sequence. The sequence matters.

Where Money Leaves

Most B2B teams skip the diagnostic phase and go straight to solutions: a new CRM, a new sales methodology, a new VP of Sales. These changes consume budget and political capital. They occasionally work. More often, they treat the symptom while the structural problem persists underneath.

A VP of Sales hired into a company with an undefined ideal customer profile (ICP) and no pricing governance will fail within 18 months, regardless of their track record. A new CRM deployed without data governance will produce cleaner-looking confusion. The investment in change management is wasted if the diagnosis was wrong.

The cost of skipping the diagnostic is not just the wasted spend. It is the 12 to 18 months of false confidence that follows while a deeper problem compounds.

Building the System

Work through these three diagnostic areas over 90 days.

Step 1: Days 1 to 30, Commercial baseline. Pull four numbers: average discount rate by segment, net revenue retention by cohort, pipeline forecast accuracy over the last four quarters, and average sales cycle length by deal size. These four metrics will tell you more about your commercial system than any stack ranking of reps. If you do not have clean data for all four, that is itself a finding. Broken data infrastructure is a symptom of broken commercial governance.

Checklist for the baseline phase:

• Discount rate by segment and by rep for the last 12 months
• Net revenue retention (NRR) by cohort for customers acquired in each of the last 6 quarters
• Forecast accuracy: what you called 90 days out versus what closed
• Sales cycle length for deals above and below your median deal size
• Churn reason codes from your last 20 churned accounts

Step 2: Days 31 to 60, ICP and positioning audit. Your ICP is only as useful as its ability to predict retention. Pull your top 20% of accounts by NRR and your bottom 20%. List every firmographic and behavioural attribute you can identify for each group. The differences between those two lists are your actual ICP.

Checklist for the ICP audit:

• Firmographics of top-retaining versus bottom-retaining customers
• Buying trigger events: what was happening in the account when they first bought
• Stakeholder patterns: who championed internally, who opposed, who was absent from the deal
• Time-to-value: how long from contract to first meaningful outcome
• Expansion pattern: what drove upsell in the top-retaining cohort

Step 3: Days 61 to 90, Governance and cadence review. The most common finding in this phase is that governance exists on paper but not in practice. Pricing approval exists in a policy document but reps know they can work around it. Pipeline qualification criteria exist in the CRM stage definitions but are not enforced in deal reviews.

Checklist for the governance review:

• How many deals in the last quarter exceeded the stated discount floor, and what approval process was followed
• Whether pipeline stage criteria are applied consistently or vary by manager
• Whether the weekly commercial review produces at least one structural decision
• Whether product, marketing, and sales share a single definition of a qualified opportunity
• Whether NRR is reviewed at the leadership level monthly with explicit expansion and churn targets

What Falls Apart

Two findings come up repeatedly when FintastIQ runs this diagnostic with B2B companies.

The first: companies overestimate ICP precision. Ask a team to describe their ICP and they can. Ask them which specific conditions make a customer likely to churn within 18 months, and the room goes quiet. The ICP is aspirational, not operational. It describes the customers they want rather than the conditions that predict long-term value.

The second: discount rate data does not exist in a usable form. Discounting is tracked in the CRM at the deal level but never aggregated, segmented by rep, or benchmarked over time. The team knows discounting is happening. No one knows whether it is getting better or worse, or whether it is concentrated in specific segments or driven by individual rep behaviour. That information gap is expensive.

Do This in the Next Seven Days

Start with the commercial baseline. Pull the four numbers: discount rate, NRR, forecast accuracy, and cycle length. If you cannot pull them cleanly, start there. Clean data is not a finance or operations problem. It is a commercial leadership problem.

If you want to run this diagnostic with external benchmarks and a prioritised output, the FintastIQ growth diagnostic covers all three phases and produces a prioritised action plan. You can also read the operator's guide to Growth Operating System for a PE-lens (private equity) view of the same diagnostic framework.

Ninety days of structured diagnosis is not slow. It is faster than two years of solving the wrong problem.